1. Home
  2. RBBN vs RGNX Comparison

RBBN vs RGNX Comparison

Compare RBBN & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ribbon Communications Inc.

RBBN

Ribbon Communications Inc.

HOLD

Current Price

$2.62

Market Cap

493.4M

Sector

Technology

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$8.99

Market Cap

418.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBBN
RGNX
Founded
1997
2008
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
493.4M
418.1M
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
RBBN
RGNX
Price
$2.62
$8.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
8
Target Price
$4.67
$28.75
AVG Volume (30 Days)
1.0M
495.0K
Earning Date
04-28-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
170.97
18.08
EPS
0.22
N/A
Revenue
N/A
$10,393,000.00
Revenue This Year
$1.97
$51.21
Revenue Next Year
$6.69
$19.08
P/E Ratio
$10.84
N/A
Revenue Growth
N/A
126.48
52 Week Low
$1.83
$6.89
52 Week High
$4.29
$16.19

Technical Indicators

Market Signals
Indicator
RBBN
RGNX
Relative Strength Index (RSI) 54.15 51.02
Support Level $2.05 $7.68
Resistance Level $2.93 $9.41
Average True Range (ATR) 0.17 0.45
MACD -0.02 -0.04
Stochastic Oscillator 41.67 53.95

Price Performance

Historical Comparison
RBBN
RGNX

About RBBN Ribbon Communications Inc.

Ribbon Communications Inc provides communications technology to service providers and enterprises, offering software and high-performance hardware products, network solutions, and services for secure data and voice communications, as well as high-bandwidth networking for residential and enterprise customers across industries such as finance, education, government, utilities, and transportation. It operates through two segments: Cloud and Edge, which generate maximum revenue and deliver software-centric, cloud-native solutions for VoIP, VoLTE, VoNR, and unified communications, and IP Optical Networks, which support growing telecommunications traffic from 5G, distributed cloud computing, and other applications. The Company generates the majority of its revenue from the United States.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: